Further, we demonstrate that oHSV-D11mt infection specifically neutralized IGF2 not IGF1 within the TME, effectively abrogating the resistance conferred by IGF2/IGF1R signaling in both tumor and neutrophils/polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs). The gene discussed is IGF2; the disease is neoplasm.